Xilio Therapeutics Reports First Quarter 2026 Financial Results and Provides Pipeline and Business Updates

Go back to Xilio Therapeutics Reports First Quarter 2026 Financial Results and Provides Pipeline and Business Updates
(NASDAQ: XLO) Delayed: 8.90 -0.04 (0.45%)
Previous Close $8.94    52 Week High
Open $9.00    52 Week Low
Day High $9.30    P/E N/A 
Day Low $8.90    EPS
Volume 32,261